DEVELOPMENT OF A PLATFORM FOR IDENTIFICATION OF MUTANOA AND PERSONALISED VACCINATION IN CANCER PATIENTS — PRCIVEX_2535 (Q2019366): Difference between revisions
Jump to navigation
Jump to search
(Changed an Item) |
(Changed label, description and/or aliases in 2 languages: Changing unique label-description pair) |
||
| description / en | description / en | ||
Project in Italy | Project Q2019366 in Italy | ||
| description / it | description / it | ||
Progetto in Italia | Progetto Q2019366 in Italia | ||
Revision as of 04:48, 2 November 2020
Project Q2019366 in Italy
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | DEVELOPMENT OF A PLATFORM FOR IDENTIFICATION OF MUTANOA AND PERSONALISED VACCINATION IN CANCER PATIENTS — PRCIVEX_2535 |
Project Q2019366 in Italy |
Statements
986,675.87 Euro
0 references
1,329,656.71 Euro
0 references
74.21 percent
0 references
1 November 2016
0 references
31 December 2018
0 references
NOUSCOM SOCIETA' A RESPONSABILITA' LIMITATA
0 references
BIOTECNOLOGIE (Italian)
0 references
BIOTECHNOLOGY (English)
0 references
Identifiers
B88I17000390008
0 references